2m 2m 2m 2m 2m 2m 2m
FENNEC PHARMA (FENC)
NASDAQ
$10.14-$0.25 (-2.36%)
Price as of Oct 22, 2026 7:53 PM EDT- $363.9MMarket Cap
- 19.04%1-Year Change
- BiotechnologyIndustry
FENNEC PHARMA (FENC)
$10.14-$0.25 (-2.36%)
FENC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.38 | ||
Change | -$0.08 (-0.76%) | ||
Open | $10.49 | ||
High | $10.86 | ||
Low | $10.28 | ||
Previous Close | $10.46 | ||
Volume | 84,492 | ||
30-Day Average Volume | 125,147 | ||
1-Week Change | 4.01% | ||
1-Month Change | -4.86% | ||
1-Year Change | 19.04% | ||
3-Year Change | 52.42% | ||
5-Year Change | 18.09% | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $75.8M | ||
Market Cap | $363.9M | ||
Enterprise Value | $322.7M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | $2.0M | ||
Free Cash Flow | $50,000.00 | ||
EBIT | $2.0M | ||
EBITDA | $2.0M | ||
Net Working Capital | $60.1M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 158 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 9 | ||
P/E | 208 | ||
PEG | 1 | ||
Price/Free Cash Flow | 7,278 | ||
Price/Operating Cash Flow | 7,278 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue